Clinical Trials Logo

Dementia clinical trials

View clinical trials related to Dementia.

Filter by:

NCT ID: NCT04074655 Completed - Dementia Clinical Trials

Investigating the Effect of Training With a Virtual Reality Driving Simulator

Start date: September 10, 2019
Phase: N/A
Study type: Interventional

The proposed study aims to investigate the use of a driving simulator in a virtual reality (VR) environment to improve the cognition state and spatial navigation of individuals with mild/moderate memory impairment. All volunteers will be assessed by the Montreal Cognitive Assessment (MoCA),Montgomery-Asberg Depression Scale (MADRS) and Morris Water orientation tests for baseline assessment after they sign the consent form and are enrolled into the study. Participants will also be scheduled for post-intervention assessments (MADRS, Morris Water Orientation and a simple questionnaire on how they evaluate the experiment). Participants of the study will play the driving simulator daily (5 days/week) for 15-20 minutes/day over a period of 2 consecutive weeks. Participants' daily performance data are recorded and uploaded on the secure server of the Priciple Investigator (PI). Simulator Sickness Questionnaire (SSQ) test will also be run after the first session of the experiment and at the end of the training period.

NCT ID: NCT04073992 Completed - Insomnia Chronic Clinical Trials

Chronic Insomnia and CSF Markers of Dementia - Effects of Treatment

Start date: September 1, 2019
Phase: N/A
Study type: Interventional

The longstanding view has been that insomnia, and other forms of sleep disturbance, emerge as a consequence of dementia and are the result of progressive neuronal damage. However, there is growing evidence that the direction of causation may go both ways, with sleep disturbance potentially increasing vulnerability to dementia. Longitudinal studies have found that sleep disturbance often precedes and increases risk for dementia by several years. The purpose of this study is to examine whether treatment of insomnia with cognitive behavioral therapy (CBT-I) is associated with a decrease in dementia biomarkers found in cerebrospinal fluid (CSF). Fifteen adults age 30-50 with chronic insomnia will undergo overnight polysomnography and CSF sampling in the morning. This will be followed by 8 weeks of treatment with CBT-I and then repeat CSF sampling.

NCT ID: NCT04064164 Completed - Dementia Clinical Trials

Speeko for Elderspeak

Start date: December 9, 2021
Phase: N/A
Study type: Interventional

This study will test feasibility and preliminary effects of an automated and performance-based feedback app (Speeko for Elderspeak) that detects and reports the use of diminutives (terms of endearment such as honey, dearie, and sweetie), prevalent elderspeak terms linked to BPSD. Building on proof of concept established in the laboratory, the app will demonstrate feasibility at the point-of-care. Next, a clinical trial (N= 6NHs) will be conducted to test preliminary efficacy of the app for amplifying reductions in diminutives use for NH staff completing the CHATO training (3 online modules).

NCT ID: NCT04062227 Completed - Caregiver Burnout Clinical Trials

Mindfulness Based Dementia Care Study

Start date: January 25, 2019
Phase:
Study type: Observational

Mindfulness based stress reduction (MBSR) refers to a particular type of attention focused on the present moment, non-judgmental awareness, and acceptance of that experience with openness and curiosity. Mindfulness training was designed to enhance the range and use of coping skills, decrease levels of stress, improve mood, and reduce tendencies to react in maladaptive ways 1-3. Investigators are evaluating a new program, called the Mindfulness Based Dementia-Care (MBDC) in caregivers (CG) for dementia, which combines the traditional approaches with education. The overall objective of this study is to evaluate the program and explore the potential benefits of the Mindfulness Based Dementia-Care (MBDC) program. Investigators are conducting a prospective, pre-post, observational study with members participating in the MBDC program.

NCT ID: NCT04060355 Completed - Dementia Clinical Trials

Savvy System Project

Start date: August 4, 2021
Phase: N/A
Study type: Interventional

The study goal is to develop a web-based system that uses distance education methods and provides manuals and protocols to train, certify, and monitor the performance of interventionists to deliver the Savvy Caregiver program (Savvy), an evidence-based dementia family caregiver psychoeducation program. The system has a potential to increase the scalability of Savvy.

NCT ID: NCT04058886 Completed - Caregiver Clinical Trials

Telephone-delivered Mindfulness Intervention for African American Dementia Caregivers

Start date: November 15, 2019
Phase: N/A
Study type: Interventional

This study is assesses the feasibility and acceptability of telephone-delivered mindfulness training designed to alleviate caregiver burden for African-American rural caregivers of individuals with moderate to severe dementia, as defined by the caregiver. The study utilizes a single-group, uncontrolled design to test the feasibility and acceptability of the intervention for the target population.

NCT ID: NCT04054583 Completed - Dementia Clinical Trials

Impact of Renovations in Long Term Care Living Spaces on Residents With Dementia, Their Families and Staff

Start date: May 9, 2017
Phase:
Study type: Observational

A long-term care facility in central Canada planned to renovate their existing dementia care units. The overarching objective of this study was to examine the effects of the renovations on residents, family, and staff.

NCT ID: NCT04052737 Completed - Alzheimer Disease Clinical Trials

PMZ-1620 (Sovateltide) in Mild to Moderate Alzheimer's Disease

Start date: March 23, 2018
Phase: Phase 2
Study type: Interventional

This is a prospective, multicentric, randomized, double blind, placebo controlled Phase II clinical study to compare the safety and efficacy of PMZ-1620 therapy along with standard supportive care in subjects with mild to moderate Alzheimer's disease.

NCT ID: NCT04047238 Completed - Dementia Clinical Trials

Multicentre Study About the Effect of Individual Reminiscence Therapy

Start date: August 8, 2019
Phase: N/A
Study type: Interventional

This study aims to evaluate the effect of individual reminiscence therapy (RT) on the global cognitive function of people with neurocognitive disorders attending social responses and to evaluate the ability of individually applied reminiscence therapy (RT) to improve overall cognitive function, memory, executive function, mood and quality of life (QoL) of elderly people with neurocognitive impairment attending social responses. It is proposed a multicenter study with an experimental design with randomized controlled repeated measures. Participants in the intervention group will hold two RT sessions per week for three months. Control group participants will maintain their treatment as usual.

NCT ID: NCT04037501 Completed - Dementia Clinical Trials

Effectiveness of a Care Management System to Reduce Unmet Needs of Informal Caregivers of People With Dementia

GAIN
Start date: October 9, 2020
Phase: N/A
Study type: Interventional

The purpose of this study is to test the effectiveness of a computer assisted care management system to identify and reduce unmet needs for and to improve quality of life of informal caregivers of people with dementia.